sb 203580 has been researched along with emodin in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (emodin) | Trials (emodin) | Recent Studies (post-2010) (emodin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,792 | 3 | 1,102 |
| Protein | Taxonomy | sb 203580 (IC50) | emodin (IC50) |
|---|---|---|---|
| Chain A, PROTEIN KINASE CK2, ALPHA SUBUNIT | Zea mays | 1 | |
| Protein tyrosine phosphatase type IVA 3 | Homo sapiens (human) | 3.5 | |
| Estrogen receptor | Homo sapiens (human) | 2.7 | |
| Cytochrome P450 1A2 | Homo sapiens (human) | 3.73 | |
| Heme oxygenase 1 | Rattus norvegicus (Norway rat) | 1.22 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 2.5 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 2.69 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 1.04 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 0.24 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 4.32 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 3.24 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 1.22 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 0.8667 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 1.0112 | |
| Estrogen receptor beta | Homo sapiens (human) | 5.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheon, JM; Huh, S; Hwang, CH; Hyun, CG; Jung, E; Kim, EJ; Kim, YS; Lee, HY; Lee, J; Park, D | 1 |
| Huang, SQ; Huang, ZG; Mi, ZC; Qin, MY; Yang, YF; Zhang, YS; Zhang, YT; Zhong, XB; Zou, XQ | 1 |
2 other study(ies) available for sb 203580 and emodin
| Article | Year |
|---|---|
Emodin inhibits TNF alpha-induced MMP-1 expression through suppression of activator protein-1 (AP-1).
Topics: Anthracenes; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Emodin; Fibroblasts; Flavonoids; Humans; Imidazoles; Infant, Newborn; JNK Mitogen-Activated Protein Kinases; Luciferases; Male; Matrix Metalloproteinase 1; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Promoter Regions, Genetic; Pyridines; Rheum; Transcription Factor AP-1; Transfection; Tumor Necrosis Factor-alpha | 2006 |
Drug-containing serum of rhubarb-astragalus capsule inhibits the epithelial-mesenchymal transformation of HK-2 by downregulating TGF-β1/p38MAPK/Smad2/3 pathway.
Topics: Animals; Astragalus Plant; Cell Line; Cell Survival; Down-Regulation; Emodin; Epithelial Cells; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Humans; Imidazoles; Kidney Tubules; Male; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Rheum; Smad2 Protein; Smad3 Protein; Transforming Growth Factor beta1 | 2021 |